The European Commission Approves Label Update for TAKHZYRO® (lanadelumab), Expanding Its Use to a Broader Group of Paedi
- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age...
Stay updated with breaking news from Last Accessed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age...
Results announced today in a multi-country GSK-commissioned and funded survey conducted by Ipsos show that parents are less knowledgeable about meningitis compared to some other childhood infectious diseases. The aim of the survey was to gain an understanding of meningitis awareness and any potential gaps in ...
New multi-country survey finds 93% of parents couldn't identify all three of the most common meningitis symptoms.1 While 88% considered meningitis to be a serious...
ZURICH, Sept. 22, 2023 /PRNewswire/ -- Takeda (TSE:4502) (NYSE:TAK) today announced the European Medicines...
Screening programmes remain the most powerful tool to reduce cervical cancer rates in the near term, but there is a concerning decline in participation in some...